Oncolytics Biotech (oncy) Misses Q3 EPS by 25c

Oncolytics Biotech (NASDAQ: oncy) reported Q3 EPS of ($0.02), $0.25 worse than the analyst estimate of $0.23.

For earnings history and earnings-related data on Oncolytics Biotech (oncy) click here.

You May Also Be Interested In

• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
• Oncolytics Biotech (ONCY) PT Lowered to $5 at H.C. Wainwright
• Deere shares climb as fiscal Q3 earnings and revenue top estimates